Jeffrey W. Burris - 09 Feb 2026 Form 4 Insider Report for Indivior Pharmaceuticals, Inc. (INDV)

Role
Chief Legal Officer
Signature
/s/Alice Givens, Power of Attorney
Issuer symbol
INDV
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
4
Filing time
12 Feb 2026, 16:05:32 UTC
Previous filing
07 Jan 2026
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Burris Jeffrey W Chief Legal Officer 10710 MIDLOTHIAN TURNPIKE, SUITE 125, NORTH CHESTERFIELD /s/Alice Givens, Power of Attorney 12 Feb 2026 0001484322

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INDV Common Stock Award $0 +26,897 +3539% $0.000000 27,657 10 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDV Performance Stock Units Award $0 +104,300 $0.000000 104,300 09 Feb 2026 Common Stock 104,300 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
F2 On March 3, 2023, the Reporting Person was granted a conditional award for 104,300 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026.

Remarks:

Exhibit 24 Power of Attorney